Library

2,3-Dichlorfenylpiperazin

2,3-Diclorophenylpiperazine has been identified by trusted drug-checking services in 11 published analytical results during 2017, 2019, 2020, 2022. These warnings establish its presence in submitted samples, but the aggregated alert evidence does not provide enough substance-specific information to describe effects, potency, or dosage.

Classification

  • Chemical: Piperazine

Effects

  • Stimulation
  • Nausea
  • Jaw Tension
  • Insomnia
  • Headache
  • Pupil Dilation
  • Talkativeness
  • Euphoria
  • Anxiety
  • Alertness Enhancement
  • Empathy Enhancement
  • Emotional Warmth
  • Light Sensitivity
  • Open Eye Visuals
  • Increased Music Appreciation
  • Brightness Enhancement
  • Patterning
  • Color Enhancement

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

No external data sources listed for this substance yet.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

2,3-Diclorophenylpiperazine - DrugsPRO průvodce látkou

2,3-Diclorophenylpiperazine průvodce látkou, který zahrnuje účinky, dávkování a informace o minimalizaci rizik.

Related pages